Beyond 51Cr release: New methods for assessing HIV-1-specific CD8+ T cell responses in peripheral blood and mucosal tissues

Clinical and Experimental Immunology

Volumn 130, Issue 2, 2002, Pages 172-182

  Shacklett, B L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; CHROMIUM; HLA ANTIGEN CLASS 1; VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; BLOOD; CELL KILLING; CELLULAR IMMUNITY; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOLOGY; KINETICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIROLOGY; VIRUS REPLICATION; ANIMAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOTOXICITY TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INTESTINE MUCOSA; MACACA; METHODOLOGY; T LYMPHOCYTE RECEPTOR GENE;

ANIMALS; ANTIGENS, VIRAL; BLOOD; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHROMIUM RADIOISOTOPES; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENES, T-CELL RECEPTOR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HUMANS; INTESTINAL MUCOSA; MACACA MULATTA;

EID: 0036025337     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01981.x     Document Type: Review

References (99)

1. Gandhi RT, Walker BD. Immunologic control of HIV-1. Annu Rev Med 2002; 53:149-72.
2. McMichael AJ, Rowland-Jones SL. Cellular immune responses to HIV. Nature 2001; 410:980-7.
3. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-85.
4. + T cells produce antiviral cytokines but are impaired in cytolytic functions. J Exp Med 2000; 192:63-75.
5. Appay V, Papagno L, Spina CA et al. Dynamics of T cell responses in HIV infection. J Immunol 2002; 168:3660-6.
6. Lieberman J, Shankar P, Manjunath N, Andersson J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 2001; 98:1667-77.
7. Shankar P, Russo M, Harnisch B, Patterson M, Skolnik P, Lieberman J. Impaired function of circulating HIV-specific CD8 (+) T cells in chronic human immunodeficiency virus infection. Blood 2000; 96:3094-101.
8. Shankar P, Xu Z, Lieberman J. Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway. Blood 1999; 94:3084-93.
9. Koup RA, Safrit JT, Cao Y et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68:4650-5.
10. Borrow P, Lewicki H, Wei X et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus [see comments]. Nat Med 1997; 3:205-11.
11. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994; 370:463-7.
12. Pantaleo G, Demarest JF, Schacker T et al. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A 1997; 94:254-8.
13. Jin X, Bauer DE, Tuttleton SE et al. Dramatic rise in plasma viremia after CD8 (+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999; 189:991-8.
14. Barouch DH, Kunstman J, Kuroda MJ et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 2002; 415:335-9.
15. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002; 296:1439-43.
16. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. Endocytosis of major histocompatibility class I molecules is induced by the HIV-Nef protein. Nat Med 1996; 2:338-42.
17. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998; 391:397-401.
18. Zajac AJ, Blattman JN, Murali-Krishna K et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998; 188:2205-13.
19. + T cells. Nature 2002; 417:95-8.
20. Andersson J, Behbahani H, Lieberman J et al. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. Aids 1999; 13:1295-303.
21. Chen G, Shankar P, Lange C et al. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood 2001; 98:156-64.
22. Trimble LA, Shankar P, Patterson M, Daily JP, Lieberman J. Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation. J Virol 2000; 74:7320-30.
23. Champagne P, Ogg GS, King AS et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410:106-11.
24. Coligan J, Kruisbeek A, Margulies D, Shevach E, Strober W, eds. Current Protocols in Immunology. New York: Wiley Interscience.
25. Nixon DF, Townsend AR, Elvin JG, Rizza CR, Gallwey J, McMichael AJ. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 1988; 336:484-7.
26. Doherty PC. The new numbers game for virus-specific CD8+ T cells. Science 1998; 280:227.
27. + T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998; 187:1395-402.
28. + memory T cells. J Exp Med 1997; 186:859-65.
29. + T cells specific for EBV in healthy virus carriers. J Immunol 1999; 162:1827-35.
30. Liu L, Chahroudi A, Silvestri G et al. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat Med 2002; 8:185-9.
31. Sheehy ME, McDermott AB, Furlan SN, Klenerman P, Nixon DF. A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J Immunol Meth 2001; 249:99-110.
32. Lecoeur H, Fevrier M, Garcia S, Riviere Y, Gougeon ML. A novel flow cytometric assay for quantitation and multi-parametric characterization of cell-mediated cytotoxicity. J Immunol Meth 2001; 253:177-87.
33. + T cell memory: Relationships between epitope specificity, cell phenotype, and immediate effector function. J Immunol 2001; 167:2019-29.
34. + T cells. J Immunol 2002; 168:4184-91.
35. Sandberg JK, Fast NM, Nixon DF. Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8 (+) T lymphocytes. J Immunol 2001; 167:181-7.
36. + T cells. J Exp Med 1997; 186:1407-18.
37. + T cells. J Immunol 2002; 168:2247-54.
38. Wagner L, Yang OO, Garcia-Zepeda EA et al. Beta-chemokines are released from HIV-1-specific cytolytic T cell granules complexed to proteoglycans. Nature 1998; 391:908-11.
39. Maecker HT, Maino VC, Picker LJ. Immunofluorescence analysis of T cell responses in health and disease. J Clin Immunol 2000; 20:391-9.
40. Abbas AK, Lichtman AH, Pober JS. Cellular and Molecular Immunology, 4th Edn. Philadelphia: WB Saunders Co, 2000.
41. Moretto WJ, Drohan LA, Nixon DF. Rapid quantification of SIV-specific CD8 T cell responses with recombinant vaccinia virus ELISPOT or cytokine flow cytometry. AIDS 2001; 14:2625-7.
42. Kern F, Surel IP, Brock C et al. T cell epitope mapping by flow cytometry. Nat Med 1998; 4:975-8.
43. Betts MR, Ambrozak DR, Douek DC et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4 (+) and CD8 (+) T cell responses: Relationship to viral load in untreated HIV infection. J Virol 2001; 75:11983-91.
44. Betts MR, Casazza JP, Patterson BA et al. Putative immunodominant human immunodeficiency virus-specific CD8 (+) T-cell responses cannot be predicted by major histocompatibility complex class I haplotype. J Virol 2000; 74:9144-51.
45. Ogg GS, Jin X, Bonhoeffer S et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998; 279:2103-6.
46. Altman JD, Moss PA, Goulder PJ et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274:94-6.
47. + T cell responses. Immunol Lett 1999; 66:77-80.
48. Mothe BR, Horton H, Carter DK et al. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection. J Virol 2002; 76:875-84.
49. Czerkinsky CC, Nilsson LA, Nygren H, Ouchterlony O, Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Meth 1983; 65:109-21.
50. Czerkinsky C, Andersson G, Ekre HP, Nilsson LA, Klareskog L, Ouchterlony O. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Meth 1988; 110:29-36.
51. Murali-Krishna K, Altman JD, Suresh M et al. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 1998; 8:177-87.
52. Larsson M, Jin X, Ramratnam B et al. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS 1999; 13:767-77.
53. van der Meide PH, Groenestein RJ, de Labie MC, Heeney J, Pala P, Slaoui M. Enumeration of lymphokine-secreting cells as a quantitative measure for cellular immune responses in rhesus macaques. J Med Primatol 1995; 24:271-81.
54. + T cells. J Immunol 2000; 165:1182-90.
55. + T cell responses using autologous dendritic cells. AIDS 2002; 16:171-80.
56. World Health Organization (WHO) Weekly Epidemiol Record 1998; 73:381-4.
57. Altfeld MA, Trocha A, Eldridge RL et al. Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: Rapid characterization of CTL responses by enzyme-linked immunospot assay. J Virol 2000; 74:8541-9.
58. Goulder PJ, Addo MM, Altfeld MA et al. Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by ELISPOT and intracellular cytokine staining assays. J Virol 2001; 75:1339-47.
59. + T cell response to human cytomegalovirus: The 72-kD major immediate-early protein revisited. J Virol 1999; 73:8179-84.
60. + T cells in peripheral blood. Viral Immunol 2001; 14:59-69.
61. Campbell JJ, Murphy KE, Kunkel EJ et al. CCR7 expression and memory T cell diversity in humans. J Immunol 2001; 166:877-84.
62. Oehen S, Brduscha-Riem K. Differentiation of naive CTL to effector and memory CTL. Correlation of effector function with phenotype and cell division. J Immunol 1998; 161:5338-46.
63. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells. Science 2000; 290:92-7.
64. McDermott AB, Spiegel HML, Irsch J, Ogg GS, Nixon DF. A simple and rapid magnetic bead separation technique for the isolation of tetramer-positive virus-specific CD8 T cells. AIDS 2001; 15:810-2.
65. + T cell immune responses. J Immunol Meth 2002; 261:177-94.
66. O'Herrin SM, Lebowitz MS, Bieler JG et al. Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors. J Exp Med 1997; 186:1333-45.
67. Dal Porto J, Johansen TE, Catipovic B et al. A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations. Proc Natl Acad Sci USA 1993; 90:6671-5.
68. De Rosa SC, Herzenberg LA, Roederer M. 11-color, 13-parameter flow cytometry: Identification of human naive T cells by phenotype, function, and T cell receptor diversity. Nat Med 2001; 7:245-8.
69. Baumgarth N, Roederer M. A practical approach to multi-color flow cytometry for immunophenotyping. J Immunol Meth 2000; 243:77-97.
70. Bigos M, Baumgarth N, Jager GC et al. Nine color eleven parameter immunophenotyping using three laser flow cytometry. Cytometry 1999; 36:36-45.
71. Roederer M, De Rosa S, Gerstein R et al. 8 color, 10-parameter flow cytometry to elucidate complex leukocyte heterogeneity. Cytometry 1997; 29:328-39.
72. De Rosa SC, Mitra DK, Watanabe N, Herzenberg LA, Roederer M. Vdelta1 and Vdelta2 gammadelta T cells express distinct surface markers and might be developmentally distinct lineages. J Leukoc Biol 2001; 70:518-26.
73. Kalams SA, Johnson RP, Dynan MJ et al. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: Analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant. J Exp Med 1996; 183:1669-79.
74. Kalams SA, Johnson RP, Trocha AK et al. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med 1994; 179:1261-71.
75. Nixon DF, Douek D, Kuebler PJ et al. Molecular tracking of an human immunodeficiency virus nef specific cytotoxic T cell clone shows persistence of clone-specific T cell receptor DNA but not mRNA following early combination antiretroviral therapy. Immunol Lett 1999; 66:219-28.
76. Douek DC, Betts MR, Brenchley JM et al. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J Immunol 2002; 168:3099-104.
77. Brosterhus H, Brings S, Leyendeckers H et al. Enrichment and detection of live antigen-specific CD4 (+) and CD8 (+) T cells based on cytokine secretion. Eur J Immunol 1999; 29:4053-9.
78. Skinner PJ, Daniels MA, Schmidt CS, Jameson SC, Haase AT. Cutting edge. In situ tetramer staining of antigen-specific T cells in tissues. J Immunol 2000; 165:613-7.
79. Schmitz JE, Veazey RS, Kuroda MJ et al. Simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in gastrointestinal tissues of chronically SIV-infected rhesus monkeys. Blood 2001; 98:3757-61.
80. Heise C, Miller CJ, Lackner A, Dandekar S. Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J Infect Dis 1994; 169:1116-20.
81. Mattapallil JJ, Smit-McBride Z, McChesney M, Dandekar S. Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4 (+) T cell depletion in primary simian immunodeficiency virus infection. J Virol 1998; 72:6421-9.
82. + T cell depletion and viral replication in SIV infection. Science 1998; 280:427-31.
83. Mowat A, Viney J. The anatomical basis of intestinal immunity. Immunol Rev 1997; 156:145-66.
84. Couedel-Courteille A, Le Grand R, Tulliez M, Guillet J, Venet A. Direct ex vivo simian immunodeficiency virus (SIV)-specific cytotoxic activity detected from small intestine intraepithelial lymphocytes of SIV-infected macaques at an advanced stage of infection. J Virol 1997; 71:1052-7.
85. Murphey-Corb M, Wilson LA, Trichel AM et al. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa. J Immunol 1999; 162:540-9.
86. Veazey RS, Gauduin MC, Mansfield KG et al. Emergence and kinetics of simian immunodeficiency virus-specific CD8 (+) T cells in the intestines of macaques during primary infection. J Virol 2001; 75:10515-9.
87. Cromwell MA, Veazey RS, Altman JD et al. Induction of mucosal homing virus-specific CD8 (+) T lymphocytes by attenuated simian immunodeficiency virus. J Virol 2000; 74:8762-6.
88. Stevceva L, Kelsall B, Nacsa J et al. Cervicovaginal lamina propria lymphocytes: Phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251. J Virol 2002; 76:9-18.
89. Lohman BL, Miller CJ, McChesney MB. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J Immunol 1995; 155:5855-60.
90. Anton PA, Elliot J, Poles MA et al. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. AIDS 2000; 14:1761-5.
91. Poles MA, Elliott J, Taing P, Anton PA, Chen IS. A preponderance of CCR5 (+) CXCR4 (+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection. J Virol 2001; 75:8390-9.
92. Shacklett BL, Beadle TJ, Pacheco PA et al. Isolation of cytomegalovirus-specific cytotoxic T-lymphocytes from gut- associated lymphoid tissue (GALT) of HIV type 1-infected subjects. AIDS Res Hum Retroviruses 2000; 16:1157-62.
93. Shacklett BL, Beadle TJ, Pacheco PA et al. Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects. Virology 2000; 270:317-27.
94. + lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 2000; 164:1602-11.
95. Shacklett BL, Cu-Uvin S, Beadle TJ et al. Quantification of HIV-1-specific T cell responses at the mucosal cervicovaginal surface. Aids 2000; 14:1911-5.
96. Musey L, Hu Y, Eckert L, Christensen M, Karchmer T, McElrath MJ. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J Exp Med 1997; 185:293-303.
97. White HD, Musey LK, Andrews MM et al. Human immunodeficiency virus-specific and CD3-redirected cytotoxic T lymphocyte activity in the human female reproductive tract: Lack of correlation between mucosa and peripheral blood. J Infect Dis 2001; 183:977-83.
98. White HD, Prabhala RH, Humphrey SL, Crassi KM, Richardson JM, Wira CR. A method for the dispersal and characterization of leukocytes from the human female reproductive tract. Am J Reprod Immunol 2000; 44:96-103.
99. + Th1 phenotype. J Immunol 1999; 163:2306-13.